A record USD 115 billion private equity surge, explosive AI adoption, and the GLP-1 obesity drug boom are redefining global healthcare investing. Sovereign wealth funds and global investors are scrambling to capture high-growth opportunities across digital health, medtech, metabolic disease therapies, and India–GCC collaborations, as the sector races toward a USD 22 trillion future.
Related Posts
On-ground barriers stalling private adoption of ABDM : Experts
Post Views: 26 At the 5th edition of the Healthcare…
Study finds pregnancy hypertension raises women’s cardiovascular risk
Post Views: 9 The study found that women who experienced…
Delhi govt asks hospitals to follow Centre’s advisory on rational use of cough syrups in children
Post Views: 29 The Union government, in its advisory dated…